Back to top
Fidelity Advisor Biotechnology Fund: Class I: (MF: FBTIX)
(NASDAQ Mutual Funds) As of Apr 18, 2024 08:00 PM ET
$30.67 USD
-0.19 (-0.62%)
Zacks MF Rank
2-Buy of 5 2
Latest Performance as of Mar 31, 2024
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 13.26 | 1 |
| 3 months | 13.26 | 1 |
| 6 months | 33.01 | 2 |
| 1 Year | 31.89 | 1 |
| 3 Year | 5.15 | 48 |
| 5 Year | 10.39 | 28 |
| 10 Year | 9.50 | 52 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | 106.15 |
| Bear Market (10/07 - 2/09) | -25.81 |
| Bull Market (2/09 - 3/21) | 833.40 |
Load Adjusted Returns as of Mar 31, 2024
| 1 Year | 31.89 |
| 5 Year | 10.39 |
| 10 Year | 9.50 |
| Since Inception | 7.96 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2024 | 13.26 | NA | NA | NA |
| 2023 | -4.68 | 4.15 | -4.79 | 17.44 |
| 2022 | -8.28 | -13.89 | 9.24 | 6.93 |
| 2021 | -3.51 | 1.85 | 1.30 | -2.85 |
| 2020 | -11.29 | 30.38 | -0.32 | 14.94 |
| 2019 | 14.30 | -1.64 | -8.35 | 22.37 |
Annual Return
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | 13.26 | 10.98 | -7.73 | -3.29 | 32.50 | 26.08 | -3.53 | 26.15 | -23.41 | 11.36 | 34.70 |
| % Total Return Rel to Index | 2.70 | -15.25 | 10.46 | -31.97 | 14.10 | -5.40 | 0.85 | 4.35 | -35.35 | 9.97 | 21.06 |
| % Total Return Rel to Peer | 5.05 | 5.22 | 1.67 | -11.98 | 11.23 | -0.59 | -3.65 | 4.03 | -12.63 | 3.93 | 9.02 |
| % Perf Quintile vs Peer* | 0.00 | 1.00 | 2.00 | 5.00 | 1.00 | 3.00 | 4.00 | 2.00 | 5.00 | 1.00 | 1.00 |
| % Dividends | 0.00 | 0.40 | 0.00 | 0.29 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 1.28 | 0.00 | 0.80 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Capital Gains ($) | 0.00 | 0.00 | 0.00 | 5.25 | 2.84 | 1.91 | 0.59 | 0.00 | 0.00 | 1.43 | 0.60 |
| Expense Ratio | 0.00 | 0.73 | 0.73 | 0.74 | 0.75 | 0.76 | 0.79 | 0.77 | 0.78 | 0.77 | 0.80 |
* 1 = Top 20%, 5 = Bottom 20%